Pages that link to "Q36617551"
Jump to navigation
Jump to search
The following pages link to Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications (Q36617551):
Displaying 50 items.
- Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions (Q21285128) (← links)
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary (Q22241786) (← links)
- Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter (Q24620189) (← links)
- Gut Microbiota and Metabolic Health: The Potential Beneficial Effects of a Medium Chain Triglyceride Diet in Obese Individuals (Q26748972) (← links)
- Role of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolism (Q26749020) (← links)
- Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis (Q26766533) (← links)
- Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis (Q26775340) (← links)
- Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype (Q26779198) (← links)
- Obesity and insulin resistance: an abridged molecular correlation (Q26825473) (← links)
- MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease (Q26852606) (← links)
- Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease (Q26853645) (← links)
- Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer (Q26992106) (← links)
- Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease (Q27005988) (← links)
- Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease (Q27007233) (← links)
- Role of mitochondria in nonalcoholic fatty liver disease (Q27028142) (← links)
- Gender and Obesity Specific MicroRNA Expression in Adipose Tissue from Lean and Obese Pigs (Q27303508) (← links)
- Vitamin D: a new player in non-alcoholic fatty liver disease? (Q28081391) (← links)
- Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies (Q28088325) (← links)
- Tumor suppressor Menin acts as a corepressor of LXRα to inhibit hepatic lipogenesis (Q28114881) (← links)
- 12- and 15-lipoxygenases in adipose tissue inflammation (Q28274315) (← links)
- Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors (Q28394967) (← links)
- Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates (Q28478084) (← links)
- Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy (Q28485412) (← links)
- The Mammalian "Obesogen" Tributyltin Targets Hepatic Triglyceride Accumulation and the Transcriptional Regulation of Lipid Metabolism in the Liver and Brain of Zebrafish (Q28551300) (← links)
- Acetylshikonin from Zicao Prevents Obesity in Rats on a High-Fat Diet by Inhibiting Lipid Accumulation and Inducing Lipolysis (Q28552550) (← links)
- Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis (Q29619888) (← links)
- Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies (Q30234444) (← links)
- Economic Burden of Obesity: A Systematic Literature Review (Q30234748) (← links)
- High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease (Q30362727) (← links)
- Non‐alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do (Q30401022) (← links)
- Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. (Q30437623) (← links)
- Liver failure in an obese middle-aged woman after biliointestinal bypass (Q30446406) (← links)
- Assessment of causality between serum gamma-glutamyltransferase and type 2 diabetes mellitus using publicly available data: a Mendelian randomization study (Q31151847) (← links)
- Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida (Q33863205) (← links)
- Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism (Q33616976) (← links)
- Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis (Q33631151) (← links)
- Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data (Q33640536) (← links)
- Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice. (Q33669422) (← links)
- Urinary loss of tricarboxylic acid cycle intermediates as revealed by metabolomics studies: an underlying mechanism to reduce lipid accretion by whey protein ingestion? (Q33709740) (← links)
- Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. (Q33749608) (← links)
- The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study. (Q33757419) (← links)
- B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study (Q33761763) (← links)
- The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial (Q33776388) (← links)
- Crude extracts from Lycium barbarum suppress SREBP-1c expression and prevent diet-induced fatty liver through AMPK activation (Q33809697) (← links)
- An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway (Q33819857) (← links)
- The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease (Q33831711) (← links)
- Chronic niacin overload may be involved in the increased prevalence of obesity in US children (Q33867341) (← links)
- Molecular pathways in non-alcoholic fatty liver disease. (Q33890230) (← links)
- Efficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot study (Q33896092) (← links)
- Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα. (Q33944254) (← links)